Saudi Arabia vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Saudi Arabia
100.0%
in 2024
Sur
82.0%
in 2024
Saudi Arabia rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Saudi Arabia
- Sur
How they compare
Saudi Arabia currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Saudi Arabia's figure about 1.2 times Sur's.
Across all 10 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 1st and Sur ranks 2nd of 144 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.0% | 68.0% | Saudi Arabia |
| 2010s | 99.0% | 74.8% | 24.2% | Saudi Arabia |
| 2020s | 100.0% | 75.8% | 24.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Saudi Arabia or Sur?
- Saudi Arabia, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Saudi Arabia and Sur?
- 18.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Sur?
- 10 years are reported by both, from 2008 to 2024.
- How do Saudi Arabia and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Saudi Arabia ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.